dolasetron has been researched along with Colonic Inertia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wilkes, G | 1 |
Aapro, M; Alberto, P; Boyce, M; Busch, B; Kirchner, V; O'Grady, P | 1 |
1 trial(s) available for dolasetron and Colonic Inertia
Article | Year |
---|---|
Early clinical trial of MDL 73.147 EF: a new 5-HT3-receptors antagonist for the prevention of chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Female; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; Serotonin Antagonists; Vomiting | 1993 |
1 other study(ies) available for dolasetron and Colonic Inertia
Article | Year |
---|---|
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |